Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
Returns on capital
Biomea Fusion, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-209.1%
avg 708.0%
ROIC
-166.2%
avg 729.7%
ROA
-105.5%
avg -126.2%
Analysis
ROA is currently the strongest return metric at -105.5% versus its period average of -126.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Michael J. Hitchcock | Interim Chief Executive Officer & Director | USD 867.94K | 76 | — | — |
Ramses Erdtmann | Co-Founder, President, Chief Operating Officer & Director | USD 636.49K | 63 | — | — |
Caroline Perez- Dupont | Senior Vice President of Legal | — | — | — | — |
Heow Tan | Chief Technology & Quality Officer | — | 67 | — | — |
Stephan Morris | Chief Development Officer | — | — | — | — |
Ravi Upasani | Executive Vice President of Intellectual Property | — | — | — | — |
Thorsten Kirschberg | Executive Vice President of Research | — | 56 | — | — |
Compensation is shown in the reported currency; data updated Oct 3, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
4
$196,731.00
Sells
0
$0.00
Net Transaction Value
+$196,731.00
Net buying
Most Active
Erdtmann Rainer M
3 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Dec 11, 25Dec 11, 2025 | Erdtmann Rainer M Direct | Buy | $43K$42,999.00 |
| Dec 2, 25Dec 2, 2025 | Hitchcock Michael J.M. Direct | Buy | $99.2K$99,180.00 |
| Dec 1, 25Dec 1, 2025 | Erdtmann Rainer M Direct | Buy | $10.5K$10,500.00 |
| Nov 28, 25Nov 28, 2025 | Erdtmann Rainer M Direct | Buy | $44.1K$44,052.00 |
Summary
Insiders reported 4 buys worth $196,731.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $196,731.00. Erdtmann Rainer M was the most active insider with 3 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does Biomea Fusion, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about BMEA's management, answered from reported figures.
Who manages BMEA?
Biomea Fusion, Inc. (BMEA) lists 7 active executives. The top listed executive is Caroline Perez- Dupont, Senior Vice President of Legal.
Are BMEA insiders buying or selling?
Recent insider activity shows net buying of $49.11M.
Continue the stock analysis
Jump to another research area for this company.